Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsAndrew Dickinson - ...
An FDA‑approved medication called spironolactone, often prescribed as a diuretic, or water pill, for heart and blood pressure ...
UCSF researchers have found a treatment for HIV that shows potential as a long-term solution for the chronic disease that, up ...
A new study led by researchers at Emory University's Rollins School of Public Health, published Monday by JAMA Network Open, ...
Dec. 1 is World AIDS Day, but for the first time in decades, the federal government is not recognizing it. One metro Atlanta ...
Twenty years ago, Kamakshi faced stigma after her husband's death from HIV. Now, she's an outreach worker in Chennai, helping ...
Two new studies provide insights into a possible cure for HIV, and feature the work of researchers from the UW and Fred Hutchinson Cancer Center.
Pharmaceutical Technology on MSN
Over half of European HIV patients diagnosed late, ECDC report finds
The annual report, published by the European Centre for Disease Prevention and Control (ECDC), was released on 27 November ...
TLC were formed in Atlanta in 1990. They comprised of T-Boz, the late Lisa “Left Eye” Lopes, and Rozonda “Chilli” Thomas.
Health care stocks have lagged the S&P 500 in 2025 thanks in part to U.S. policy uncertainty. However, health care stocks can often be a solid defensive play in an uncertain economy. People don' ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global health officials call a game-changer. The drug developed by Gilead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results